Case Report: Diagnosis, treatment and follow-up of venous thrombosis in adolescent diabetic patients with SARS-CoV-2.

The highest risk of diabetes mellitus (DM)-related complications, collectively known as venous thromboembolism (VTE), is observed in the age group of 20-39 years. However, this observation sharply contrasts with the increased incidence of superficial venous thrombosis observed among adolescent patients during the coronavirus disease 2019 (COVID-19) outbreak in Hebei Province in December 2022. Moreover, it contradicts the absence of venous thrombosis observed in pediatric diabetic patients who were treated prior to the COVID-19 outbreak. This study collected and analyzed clinical data related to diabetic venous thrombosis in children, with the aim of provide evidence for the prevention and treatment of this complication.